Pilot study to evaluate the incidence and nature of unplanned medical visits for patients with early breast cancer during the course of their management following surgery: PATIPS-A

Status

Completed

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12613000276752

Acronym

PATIPS-A

Enrollment

Registered

2013-03-07

Start date

2013-03-01

Completion date

2015-05-01

Last updated

2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Survival from breast cancer has improved significantly over the past 30 years. This has been due to the coordinated approach of surgery, chemotherapy and/or radiation therapy with each member of your treating specialist team contributing to your treatment recommendation. For each of these three disciplines of treatment, the conduct of clinical research has led to more effective ways of performing surgery and delivery of the best drug combinations and radiation therapy. In addition, research has also aimed to reduce side effects and therefore make each of these treatment approaches, safer and less intrusive to the quality of your life. However, it is still likely that patients will experience side effects of some kind as a result of their surgery, chemotherapy and/or radiation therapy. Currently, it is not known how often the specialist treating team or the patient’s general practitioner is managing these side effects; and how successful the treatment recommended is. Understanding the frequency of side effects that lead to an unplanned visit with a member of your specialist treating team or GP and how these side effects are managed, will allow us to plan more effective ways of coordinating the care, to ultimately improve the well-being of breast cancer patients as they undergo the various stages of their breast cancer treatment.

Interventions

We are aiming to collect details of the side effects that you experience during each phase of your treatment, how often and the reason that you see your GP or specialist during your breast cancer treatment for unexpected medical problems; and what treatment is given to you for these medical problems. The information will be collected in a patient self-reported diary and sourced in routine medical practice medical file notes. Paticipants will be observed until completion of their designated treat

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

i. Patient consent ii. Consecutive patients who will be receiving radiation therapy and/or who will receive chemotherapy. iii. English is the first language iv. Residential address in the Perth greater metropolitan area v. Regular GP as defined by the patient or no regular GP available. (GP consent is not considered necessary as SP and GP have recognised joint responsibility for the patient and if the patient consents to study, it is implied that communications between the GP and SP is freely provided)

Exclusion criteria

i. Patient not to receive either chemotherapy or radiation therapy

Outcome results